1. Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'. Issue 4 (7th December 2021) Authors: Gayle, Sophia; Aiello, Robert; Leelatian, Nalin; Beckta, Jason M; Bechtold, Jane; Bourassa, Patricia; Csengery, Johanna; Maguire, Robert J; Marshall, Dan; Sundaram, Ranjini K; Van Doorn, Jinny; Jones, Kelli; Moore, Hunter; Lopresti-Morrow, Lori; Paradis, Timothy; Tylaska, Laurie; Zhang,... Journal: NAR cancer Issue: Volumer 3:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors. Issue 2 (17th May 2021) Authors: Sule, Amrita; Van Doorn, Jinny; Sundaram, Ranjini K; Ganesa, Sachita; Vasquez, Juan C; Bindra, Ranjit S Journal: NAR cancer Issue: Volumer 3:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity. Issue 2 (4th June 2021) Authors: Gayle, Sophia; Aiello, Robert; Leelatian, Nalin; Beckta, Jason M; Bechtold, Jane; Bourassa, Patricia; Csengery, Johanna; Maguire, Robert J; Marshall, Dan; Sundaram, Ranjini K; Van Doorn, Jinny; Jones, Kelli; Moore, Hunter; Lopresti-Morrow, Lori; Paradis, Timothy; Tylaska, Laurie; Zhang, Qing... Journal: NAR cancer Issue: Volumer 3:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗